MwanzoLSTA • NASDAQ
add
Lisata Therapeutics Inc
Bei iliyotangulia
$ 2.56
Bei za siku
$ 2.45 - $ 2.58
Bei za mwaka
$ 1.87 - $ 4.20
Thamani ya kampuni katika soko
22.15M USD
Wastani wa hisa zilizouzwa
elfu 52.85
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 70.00 | — |
Matumizi ya uendeshaji wa biashara | 4.94M | -10.59% |
Mapato halisi | -4.66M | 7.63% |
Kiwango cha faida halisi | elfu -6.66 | — |
Mapato kwa kila hisa | -0.54 | 11.48% |
EBITDA | -4.82M | 11.94% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 21.97M | -42.58% |
Jumla ya mali | 25.16M | -40.90% |
Jumla ya dhima | 4.38M | -4.17% |
Jumla ya hisa | 20.78M | — |
hisa zilizosalia | 8.76M | — |
Uwiano wa bei na thamani | 1.05 | — |
Faida inayotokana na mali | -44.96% | — |
Faida inayotokana mtaji | -52.89% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -4.66M | 7.63% |
Pesa kutokana na shughuli | -3.96M | 25.12% |
Pesa kutokana na uwekezaji | elfu 505.00 | -95.69% |
Pesa kutokana na ufadhili | elfu 64.00 | 100.00% |
Mabadiliko halisi ya pesa taslimu | -3.38M | -152.13% |
Mtiririko huru wa pesa | -2.34M | 34.21% |
Kuhusu
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Ilianzishwa
1980
Makao Makuu
Tovuti
Wafanyakazi
26
